RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Panaxia Labs Israel EBIT 2024

Panaxia Labs Israel EBIT

-41.97 M ILS

Panaxia Labs Israel Dividend yield

Ticker

PNAX.TA

ISIN

IL0011043630

In 2024, Panaxia Labs Israel's EBIT was -41.97 M ILS, a 108.27% increase from the -20.15 M ILS EBIT recorded in the previous year.

The Panaxia Labs Israel EBIT history

YEAREBIT (undefined ILS)
2022-
2021-
2020-
2019-
2018-
2017-
2016-
2015-
2014-

Panaxia Labs Israel Aktienanalyse

What does Panaxia Labs Israel do?

Panaxia Labs Israel Ltd is a cannabis-based medical technology company specializing in the development, manufacturing, and marketing of innovative pharmaceutical products and technologies. It was founded in 2010 by pharmacist Dr. Dadi Segal and lawyer Assi Rotbart with the goal of improving and facilitating the treatment of patients with specific medical needs. The company is headquartered in Rosh Ha'Ayin, a city near Tel Aviv, Israel, and is the first and currently only company in Israel to offer complete vertical integration from research and development to the marketing and distribution of medical cannabis products. Panaxia Labs Israel's business model includes collaboration with leading scientists and medical institutions to develop groundbreaking medical technologies and products based on medical cannabis. The company has already received various awards for its innovative products and technologies and is currently active in various industries. One of the main divisions of Panaxia Labs Israel is the production of medical cannabis products for the treatment of various conditions. The products are manufactured under strict quality standards and include a variety of cannabinoids such as THC, CBD, and others, which help patients relieve pain, reduce inflammation, and treat other symptoms. The company also offers an innovative technology called "Panaxia Smart Inhaler" that allows patients to receive the precise dosage they need without experiencing the harmful effects of smoking or vaping. The technology uses an advanced microprocessor platform to monitor the amount of medical cannabis the patient inhales and sends this data to an app that facilitates patient control and monitoring. Panaxia Labs Israel also has a partnership with Tel Aviv University to develop a cream based on medical cannabis for the treatment of psoriasis. The cream is currently in phase 2 clinical trials and has the potential to become a revolutionary treatment method for this severe skin condition. In addition to developing medical cannabis products, Panaxia Labs Israel also works closely with the military industry to develop new technologies and products for use in the medical treatment of soldiers and other military personnel. The company has obtained a license to cultivate and manufacture medical cannabis on behalf of the Israeli Ministry of Defense and is working on developing new and innovative technologies to improve army health and facilitate the treatment of injuries. In summary, Panaxia Labs Israel is a leading company in the medical cannabis industry specializing in the development and marketing of innovative products and technologies for the treatment of various conditions. With its strong research and development expertise, close collaboration with leading medical institutions and the military industry, and a wide portfolio of products and services, the company has the potential to play an important role in the treatment of medical conditions in the future. Panaxia Labs Israel ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Panaxia Labs Israel's EBIT

Panaxia Labs Israel's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Panaxia Labs Israel's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Panaxia Labs Israel's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Panaxia Labs Israel’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Panaxia Labs Israel Stock

How much did Panaxia Labs Israel achieve in EBIT for the current year?

In the current year, Panaxia Labs Israel has achieved an EBIT of -41.97 M ILS.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Panaxia Labs Israel.

How has the EBIT of Panaxia Labs Israel developed in recent years?

The EBIT of Panaxia Labs Israel has increased by 108.268% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Panaxia Labs Israel?

The EBIT of Panaxia Labs Israel is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Panaxia Labs Israel pay?

Over the past 12 months, Panaxia Labs Israel paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Panaxia Labs Israel is expected to pay a dividend of 0 ILS.

What is the dividend yield of Panaxia Labs Israel?

The current dividend yield of Panaxia Labs Israel is .

When does Panaxia Labs Israel pay dividends?

Panaxia Labs Israel pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Panaxia Labs Israel?

Panaxia Labs Israel paid dividends every year for the past 0 years.

What is the dividend of Panaxia Labs Israel?

For the upcoming 12 months, dividends amounting to 0 ILS are expected. This corresponds to a dividend yield of 0 %.

In which sector is Panaxia Labs Israel located?

Panaxia Labs Israel is assigned to the 'Health' sector.

Wann musste ich die Aktien von Panaxia Labs Israel kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Panaxia Labs Israel from 6/15/2012 amounting to 1.074 ILS, you needed to have the stock in your portfolio before the ex-date on 6/3/2012.

When did Panaxia Labs Israel pay the last dividend?

The last dividend was paid out on 6/15/2012.

What was the dividend of Panaxia Labs Israel in the year 2023?

In the year 2023, Panaxia Labs Israel distributed 0 ILS as dividends.

In which currency does Panaxia Labs Israel pay out the dividend?

The dividends of Panaxia Labs Israel are distributed in ILS.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Panaxia Labs Israel

Our stock analysis for Panaxia Labs Israel Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Panaxia Labs Israel Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.